naltrexone and Animal Mammary Carcinoma

naltrexone has been researched along with Animal Mammary Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrouin-Melo, SM; Borges, NF; D'Assis, MJMH; da Costa-Neto, JM; Estrela-Lima, A; Machado, MC; Martins-Filho, OA; Portela, RD; Silva, FL	1

Other Studies

1 other study(ies) available for naltrexone and Animal Mammary Carcinoma

Article	Year
The effect of naltrexone as a carboplatin chemotherapy-associated drug on the immune response, quality of life and survival of dogs with mammary carcinoma. PloS one, 2018, Volume: 13, Issue:10 Topics: Animals; beta-Endorphin; Carboplatin; Dogs; Drug Synergism; Enkephalin, Methionine; Female; Immunophenotyping; Lymphocytes; Mammary Neoplasms, Animal; Mastectomy; Naltrexone; Neoplasm Metastasis; Quality of Life; Survival Analysis; Treatment Outcome	2018

Article

Year

The effect of naltrexone as a carboplatin chemotherapy-associated drug on the immune response, quality of life and survival of dogs with mammary carcinoma.

PloS one, 2018, Volume: 13, Issue:10

Topics: Animals; beta-Endorphin; Carboplatin; Dogs; Drug Synergism; Enkephalin, Methionine; Female; Immunophenotyping; Lymphocytes; Mammary Neoplasms, Animal; Mastectomy; Naltrexone; Neoplasm Metastasis; Quality of Life; Survival Analysis; Treatment Outcome

2018